Safety and immunogenicity of a recombinant Plasmodium falciparum AMA1-DiCo malaria vaccine adjuvanted with GLA-SE or Alhydrogel® in European and African adults: A phase 1a/1b, randomized, double-blind multi-centre trial
| Autor: | Ouedraogo, E., Sanou, G., Gueguen, S., Lopez Perez, E., Ammour, K., Kocken, C., Batteux, F., Tartour, E., Sirima, S.B., Durier, C., Kara, L., Houard, S., Gansane, A., Loulergue, P., Bahuaud, M., Benhamouda, N., Nebié, I., Faber, B., Remarque, E., Launay, O. |
|---|---|
| Zdroj: | In Vaccine 27 October 2017 35(45):6218-6227 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect